|  | Control | Intervention | Treatment effect |
---|---|---|---|---|
By Accelerometer n: baseline, 28 weeks | n = 72, 39 | n = 68, 36 |  | |
Sedentary | Baseline | 1172 (95) | 1165 (91) | |
 | 28 weeks | 1175 (86) | 1197 (77) | 21 (−13 to 55) |
Active | Baseline | 217 (65) | 225 (58) | |
 | 28 weeks | 209 (82) | 194 (68) | −11 (−42 to 19) |
Light | Baseline | 178 (54) | 184 (50) | |
 | 28 weeks | 175 (81) | 161 (61) | −9 (−38 to 19) |
MVPA | Baseline | 40 (20) | 42 (20) | |
 | 28 weeks | 34 (18) | 33 (15) | −2 (−9 to 5) |
By RPAQ Questionnaire n: baseline, 28 weeks | n = 80, 54 | n = 79, 56 |  | |
Sedentary | Baseline | 1007(207) | 1009 (187) | Â |
 | 28 weeks | 1068(177) | 1020 (226) | −50 (−115 to 16) |
Active | Baseline | 408 (189) | 415 (180) | Â |
 | 28 weeks | 367 (175 | 410 (219) | 45 (−16 to 106) |
Light | Baseline | 354 (180) | 356 (164) | Â |
 | 28 weeks | 333 (165) | 340 (204) | 11 (−46 to 68) |
MVPA | Baseline | 54 (87) | 60 (99) | Â |
 | 28 weeks | 34 (52) | 70 (78) | 34 (9 to 59) |